AI assistant
Sending…
Beam Therapeutics Inc. — Director's Dealing 2021
Jan 11, 2021
31533_dirs_2021-01-11_f4fc310e-42dc-4864-934a-27b75a01de47.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2021-01-10
Reporting Person: Walsh Kathleen E (Director)
More from Beam Therapeutics Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Director's Dealing
2026
Feb 26
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 12
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Feb 5
Major Shareholding Notification
2026
Feb 3